Showing results (81-90 of 755) with videos related to
Sort By:
Pageof 76
Digestive Diseases (Basel, Switzerland)|September 15, 2015
Molecular Endoscopy and in vivo Imaging in Inflammatory Bowel DiseasesMarkus F NeurathCytokine & Growth Factor Reviews|June 17, 2020
IL-36 in chronic inflammation and cancerMarkus F NeurathTherapeutic Advances in Gastroenterology|October 26, 2020
Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitisIngo Ganzleben, Carol Geppert, Lourdes Osaba, et al.Journal of Crohn'S & Colitis|August 19, 2020
The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammationKatharina Gerlach, Kristina Lechner, Vanessa Popp, et al.The Journal of Allergy and Clinical Immunology|June 17, 2015
Usefulness of recombinant γ-gliadin 1 for identifying patients with celiac disease and monitoring adherence to a gluten-free dietBharani Srinivasan, Margarete Focke-Tejkl, Milena Weber, et al.Therapeutic Advances in Gastroenterology|July 5, 2022
Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitisLaura Besendorf, Tanja M Müller, Carol-Immanuel Geppert, et al.Frontiers in Medicine|October 26, 2023
Healing of the epithelial barrier in the ileum is superior to endoscopic and histologic remission for predicting major adverse outcomes in ulcerative colitisTimo Rath, Raja Atreya, Julia Bodenschatz, et al.Inflammatory Bowel Diseases|May 23, 2018
Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-sMarie-Theres Binder, Emily Becker, Maximilian Wiendl, et al.Endoscopy|December 19, 2014
Confocal laser endomicroscopy for the differential diagnosis of ulcerative colitis and Crohn's disease: a pilot studyGian Eugenio Tontini, Jonas Mudter, Michael Vieth, et al.Therapeutic Advances in Gastroenterology|January 2, 2024
Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitisFrancesco Vitali, Timo Rath, Entcho Klenske, et al.Pageof 76